Literature DB >> 16053453

Modern approach in treatment of diabetes insipidus.

Elvedina Kapić1, Fahir Becić, Maida Todić.   

Abstract

In this paper we have reviewed the position of desmopressin in the treatment of diabetes insipidus. Desmopressin is a synthetic analog of vasopressin, with more pronounced antidiuretic effect. It is treatment of choice in substitution therapy of diabetes insipidus. Its application before sleeping time can reduce nocturnal enuresis, so it has a place in the treatment of enuresis nocturna. Antidiuretic effect of desmopressin is the result of agonistic effect on V2 receptors in the renal tubules. The efficacy and safety of desmopressin in mentioned indications was confirmed in clinical studies.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16053453      PMCID： PMC7214070          DOI： 10.17305/bjbms.2005.3282

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN： 1512-8601            Impact factor:   3.363


  16 in total

1.  Desmopressin resistant enuresis: pathogenetic and therapeutic considerations.

Authors:  T Nevéus; G Läckgren; T Tuvemo; U Olsson; A Stenberg
Journal:  J Urol       Date:  1999-12       Impact factor: 7.450

Review 2.  Desmopressin--a haemostatic drug: state-of-the-art review.

Authors:  S Lethagen
Journal:  Eur J Anaesthesiol Suppl       Date:  1997-03

3.  Central nervous system ischemia after varicella infection and desmopressin therapy for enuresis.

Authors:  J M Wieting; D D Dykstra; M P Ruggiero; G B Robbins; K Galusha
Journal:  J Am Osteopath Assoc       Date:  1997-05

4.  A clinical feature of hyperlipidemia in patients with central diabetes insipidus.

Authors:  M Takahashi-Tezuka; J Kobayashi; M Otabe; A Hirai; J Tashiro; H Bujo; N Morisaki; Y Saito; S Yoshida
Journal:  Endocr J       Date:  2000-10       Impact factor: 2.349

5.  Hyponatraemic convulsion secondary to desmopressin treatment for primary enuresis.

Authors:  D C Apakama; A Bleetman
Journal:  J Accid Emerg Med       Date:  1999-05

6.  Oral desmopressin for nocturnal polyuria in elderly subjects: a double-blind, placebo-controlled randomized exploratory study.

Authors:  R Asplund; B Sundberg; P Bengtsson
Journal:  BJU Int       Date:  1999-04       Impact factor: 5.588

7.  Desmopressin for nocturnal enuresis in nephrogenic diabetes insipidus.

Authors:  Dominik Müller; Nannette Marr; Tobias Ankermann; Paul Eggert; Peter M T Deen
Journal:  Lancet       Date:  2002-02-09       Impact factor: 79.321

8.  The UK guidelines for the use of desmopressin in patients with von Willebrand's disease. Von Willebrand Working Party of the United Kingdom Haemophilia Centre Director's Organization.

Authors:  S Lethagen; P Flordal; H Van Aken; B J Hunt; M Cattaneo
Journal:  Eur J Anaesthesiol Suppl       Date:  1997-03

9.  Low-dose desmopressin in the treatment of nocturnal urinary incontinence in the exstrophy-epispadias complex.

Authors:  P Caione; S Nappo; R De Castro; M Prestipino; N Capozza
Journal:  BJU Int       Date:  1999-08       Impact factor: 5.588

10.  Long-term use and tapered dose reduction of intranasal desmopressin in the treatment of enuretic children.

Authors:  M Riccabona; J Oswald; P Glauninger
Journal:  Br J Urol       Date:  1998-05
View more
  2 in total

1.  3T renal (23)Na-MRI: effects of desmopressin in patients with central diabetes insipidus.

Authors:  Stefan Haneder; Henrik J Michaely; Simon Konstandin; Lothar R Schad; John N Morelli; Bernhard K Krämer; Stefan O Schoenberg; Alexander Lammert
Journal:  MAGMA       Date:  2013-04-06       Impact factor: 2.310

2.  dDAVP Downregulates the AQP3-Mediated Glycerol Transport via V1aR in Human Colon HCT8 Cells.

Authors:  Mariangela Centrone; Mariagrazia D'Agostino; Marianna Ranieri; Maria Grazia Mola; Pinuccia Faviana; Piero Vincenzo Lippolis; Domenico Alessandro Silvestris; Maria Venneri; Annarita Di Mise; Giovanna Valenti; Grazia Tamma
Journal:  Front Cell Dev Biol       Date:  2022-07-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.